Atorvastatin in Relapsing-Remitting Multiple Sclerosis

NCT00616187 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: interferon beta treatment to add-on atorvastatin treatment
DRUG: untreated to atorvastatin treatment

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]
[object Object]
[object Object]